メナキノン-4、および構造類縁体がステロイド産生、およびインスリン分泌に与える影響 by 何 欣蓉
The effects of menaquinone-4 and its
structurally related compound on
steroidogenesis and insulin secretion
著者 何 欣蓉
号 52
学位授与機関 Tohoku University
学位授与番号 農博第1153号
URL http://hdl.handle.net/10097/00122786
カ キンヨウ
氏 名 （ 本 籍 地 ） 何 欣  蓉
学 位 の 種 類 博士（農学）
学 位 記 番 号 農博第 1153 号 
学 位 授 与 年 月 日 平成 28 年 3 月 25 日 
学 位 授 与 の 要 件 学位規則第４条第１項
研 究 科 ， 専 攻 東北大学大学院農学研究科（博士課程）生物産業創成科学専攻
論 文 題 目 The effects of menaquinone-4 and its structurally related compound on 
steroidogenesis and insulin secretion（メナキノン-4、および構造類縁体がス
テロイド産生、およびインスリン分泌に与える影響）
博士論文審査委員 （主査）教 授 駒井 三千夫
教 授 種村 健太郎
准教授 仲川 清隆
准教授 白川 仁
379
 論文内容要旨 
 
The effects of menaquinone-4 and its structurally 
related compound on steroidogenesis and insulin 
secretion. 
(メナキノン-4、および構造類縁体がステロイド産
生、およびインスリン分泌に与える影響) 
 
 
 
 
東北大学大学院農学研究科 
生物産業創成科学専攻 
何 欣蓉 
 
指導教員 
駒井 三千夫 教授
 
380
1 
 
Chapter 1 Introduction 
Vitamin K is a fat soluble vitamin which is involved in blood coagulation and bone 
metabolism. Naturally existing vitamin K (K) includes vitamin K1 (K1) and K2 (K2). 
Menaquinone-4 (MK-4) is one of the K2 family and conversion product from K1. 
Geranylgeraniol (GGOH) is a C20 isoprenoid compound that plays an important role in 
several biological processes, and has been also considered as a functional side chain 
component of MK-4.  
Testosterone plays an important role in fetal development, sperm production, and 
the development of male secondary sex characteristics. A population-based study showed 
that free serum testosterone levels decrease with age in Japanese men aged 40–79 years. 
Low testosterone levels cause infertility and sexual dysfunction in men, with a subset of 
men developing late-onset hypogonadism. Low testosterone can also predict the 
development of type 2 diabetes and cardiovascular disease and has been linked to 
increased risk of mortality in men.  
In men, testosterone is produced by Leydig cells in the testicles. As shown in Fig. 
1, steroidogenic acute regulatory protein (StAR) transports cholesterol to the inner 
mitochondrial membrane in these cells to initiate steroidogenesis. P450scc (also known 
as CYP11A), a cholesterol side chain cleavage enzyme, catalyzes a cascade of reactions 
that converts cholesterol to the steroid hormone precursor pregnenolone, which is 
converted to testosterone. Steroid synthesis is also regulated by multiple signaling events, 
including adenylate cyclase (AC) activation and elevation of intracellular cAMP levels, 
followed by activation of protein kinase A (PKA) and other steroidogenic proteins. We 
previously showed that MK-4 and GGOH can enhance testosterone production in rats and 
in mouse testis-derived I-10 cells. Here, we further clarified the mechanism of enhanced 
testosterone and progesterone production by MK-4 and GGOH in the present study using 
I-10 tumor cells. 
Another important issue now is that type 2 diabetes is a common and serious 
global health problem and is increasing rapidly worldwide. Type 2 diabetes frequently 
results from progressive failure of pancreatic β-cell function in the presence of insulin 
resistance. 
Previous study showed that MK-4 and GGOH induced insulin secretion in a dose- 
and time-dependent manner after stimulated with glucose in cultured mouse pancreatic 
islets. Therefore, the present study investigated the effect of MK-4 and GGOH on 
glucose-stimulated insulin secretion (GSIS), then further clarified the mechanism of MK-
4 and GGOH modulating insulin secretion in rat insulinoma INS-1 cells.  
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Chapter 2 MK-4 and GGOH stimulate steroidogenesis by modulating PKA and 
AC activities but not phosphodiesterase (PDE) in a cAMP-dependent manner in I-
10 cells 
To determine whether MK-4 and its side-chain structurally related compound— 
GGOH enhance testosterone production, I-10 cells were treated with MK-4 and GGOH 
(0–30 μM for 24 h). MK-4 and GGOH enhanced testosterone level in the culture medium 
in a dose-dependent manner (Fig. 2A and 2B). Similarly, the level of progesterone—a 
testosterone precursor—was also increased in a dose- dependent manner following 
treatment with MK-4 and GGOH (Fig. 2C and 2D).  
Moreover, the ability of structurally related isoprenoids to stimulate 
steroidogenesis was also examined. Our pervious experiments found that testosterone and 
progesterone levels in I-10 cells culture medium were markedly increased in the presence 
of phytol and geranylgeranyl diphosphate; meanwhile, farnesol enhanced progesterone 
but not testosterone level. In Fig. 3, we used γ-tocotrienol (γ-T3), the member of vitamin 
E family and it has a farnesyl isoprenoid side chain, as structurally close to MK-4. For 
these experiments, we used 0.3-3 μM γ-T3 to investigate the effects of γ-T3 on 
testosterone and progesterone levels (Fig. 3A and 3B), it is consistent with the effects of 
farnesol in our previous study, progesterone but not testosterone level were increased by 
γ-T3 treatments in a dose-dependent manner. 
We considered that MK-4 and GGOH increase steroidogenesis via regulating 
cAMP/PKA pathway in I-10 cells. To test this hypothesis, we first assessed the effect of 
MK-4 and GGOH on PKA activity with the CRE-driven reporter gene assay. We found 
that 30 μM MK-4 induced luciferase activity and 30 μM GGOH showed a tendency to 
induce luciferase activity relative to the control (Fig. 4A). The increase in progesterone 
level induced by MK-4 (Fig. 4B) and GGOH (Fig. 4C) was completely abolished by 
treatment with the PKA inhibitor H89. Furthermore, intracellular cAMP level was 
increased in a dose-dependent manner by treatment with MK-4 and GGOH for 1.5 h (Fig. 
5A and 5B). These results indicate that MK-4 and GGOH enhance testosterone and 
progesterone production via regulation of PKA activity in a cAMP-dependent pathway. 
To clarify the mechanism underlying the effects of MK-4 and GGOH on the 
cAMP/PKA pathway and steroidogenesis in I-10 cells, we inhibited the activities of two 
enzymes that regulate cAMP level—i.e., AC and phosphodiesterase (PDE) using 
MDL12,330A and IBMX, respectively. Although the effects of 10 and 30 μM MK-4 on 
progesterone production were blocked in the presence of MDL12,330A, it did not show 
the a significant difference relative to the control (Fig. 6A); however the GGOH-induced 
increases in progesterone level were suppressed in the presence of MDL12,330A (Fig. 
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6B). On the other hand, in Fig. 7A and 7B, we first used the low dose (5 μM) of IBMX 
to clarify the effects of MK-4 and GGOH on PDE activity, the results revealed that both 
MK-4 and GGOH did not suppress PDE in I-10 cells; even so, to reconfirm the results, 
in Fig. 7C, IBMX was affirmed as a non-toxic inhibitor under high concentration (50 μM) 
in I-10 cells. We then used 50 μM IBMX to compare the effects of MK-4 and GGOH in 
the deficiency of PDE activity (Fig. 7D and 7E), and it did not exhibit any significant 
differences between absence and presence of IBMX, which suggesting that MK-4 and 
GGOH regulate cAMP concentration by inducing AC activity and not by suppressing 
PDE. 
 
Chapter 3 MK-4 and GGOH induce the upregulation of steroidogenesis- related 
genes and proteins in I-10 cells 
To further clarify the mechanism by which GGOH induces steroidogenesis via the 
cAMP/PKA axis, the mRNA and protein expression levels of steroidogenesis-related 
genes were measured. We first estimated Ac1-Ac10, Cyp11a, and StAR mRNA 
expressions after 1 or 3 h of MK-4 and GGOH treatments. Here we only found that the 
expression of Ac9 increased following MK-4 treatment for 3 h (Fig. 8), and StAR mRNA 
expression increased after 3 h of GGOH treatment. There was no significant change in 
Cyp11a mRNA expression. However, as for the protein levels, it is consistent with the 
effect of GGOH on StAR mRNA level, StAR protein levels enhanced especially at 3 h 
and 6 h of GGOH treatment, as shown in Fig. 9. Cyp11a protein level was also enhanced 
after 3 h of GGOH treatment (Fig. 10). These results indicate that MK-4 and GGOH 
induces the upregulation of steroidogenesis-related genes expression via the cAMP/PKA 
signaling pathway to enhance steroid production. 
To confirm that MK-4 and GGOH stimulate steroidogenesis via induction of AC 
activity, we knocked down Ac3 and Ac9 expression by using siRNA. Our previous study 
found that the Ac9 isoform was highly expressed in I-10 cells and Ac3 isoform expression 
was enhanced following forskolin treatment. In Fig. 11, the effect of Ac9 and Ac3 
knockdown on progesterone production in I-10 cells was shown. The cells were treated 
with forskolin (as ACs activator), MK-4 and GGOH for 3 h after siRNA transfection. In 
Ac9-deficient cells, GGOH treatment had no effect on progesterone levels relative to the 
control group that forskolin still enhanced progesterone levels in Ac9-deficient cells (Fig. 
11A), and it is consistent with the reports that forskolin only activate Ac1-8 but not Ac9. 
In addition, by using Ac3-deficient cells, the enhancement of progesterone level by 
forskolin and GGOH were abolished (Fig 11B). However, we did not find the evidence 
of MK-4 on Ac3 or Ac9 activation here. These results indicate that GGOH, but not MK-
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4, stimulates steroidogenesis via regulation of Ac activity. 
 
Chapter 4 MK-4 but not GGOH promotes glucose-stimulated insulin secretion in 
INS-1 cells 
According to previous the results, we hypothesized that MK-4 and GGOH can 
also regulate glucose-stimulated insulin secretion (GSIS) via modulating cAMP/PKA 
signaling pathway in pancreatic β-cells. To determine the dosage of MK-4 and GGOH, 
we first analyzed the cell survival rate of INS-1 β-cells by using WST-1 assay, when the 
concentrations of MK-4 and GGOH under 3 μM and 10μM did not bring any toxicity 
effects in INS-1 cells, respectively. The concentrations of MK-4 (3 μM) and GGOH (10 
μM) were used for the following experiments. In Fig. 12, GGOH did not increase the 
GSIS in INS-1 cells in the case of 2.8 mM glucose stimulation, whereas 3 μM of MK-4 
enhanced insulin secretion even in the basal level of glucose stimulation (2.8 mM). 
Further experiments showed that 3 μM of MK-4 increased the insulin secretion with 
glucose dose-dependent manner (Fig. 13). To further clarify the role of MK-4 and GGOH 
on GSIS, the cAMP levels were measured (Fig. 14), and 1 and 3 μM of MK-4 enhanced 
cAMP levels (Fig. 14A), however, cAMP levels did not promoted by the 1-10 μM of 
GGOH treatment (Fig. 14A and 14B). In addition, through CRE-reporter gene assay, it 
was found that the luciferase activity in 1-3 μM of MK-4 and 10 μM GGOH treatment 
had no effect on PKA activity in INS-1 cells (Fig. 15A and 15B). Finally, we also 
determined the mRNA levels of Ac in INS-1 cells, and found that Ac6, Ac8 and Ac9 were 
highly expressed in INS-1 cells, therefore we firstly investigate the effects of MK-4 on 
the mRNA expression of Acs for 30 min and 60 min treatments (Fig. 16). We did not find 
any significant difference on the mRNA levels of Ac6, Ac8 and Ac9 after MK-4 treatment 
in INS-1 cells. Further clarification of the mechanism involved in the effect of MK-4 on 
GSIS is necessary in INS-1 cells by using other methods in the near future. 
 
Chapter 5 Conclusion 
In the present study, we focused on the effects of MK-4 and GGOH on 
steroidogenesis and glucose-stimulated insulin secretion. MK-4 enhanced not only 
steroidogenesis but also insulin secretion, and it might be due to regulation of the 
cAMP/PKA signaling pathway. These findings provide novel mechanistic insight into the 
process of steroidogenesis and may be useful for the development of therapeutic strategies 
to counter age-associated declines in testosterone levels in men. 
On the other hand, GGOH markedly enhanced steroidogenesis in I-10 cells, but 
there is no change on GSIS in INS-1 cells. These results showed that MK-4 and GGOH 
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have similar functions in steroidogenesis, but different effect on GSIS. Further studies 
should be conducted to clarify the mechanism of MK-4 and GGOH on GSIS. In 
conclusion, the present study has demonstrated 
1. MK-4 and GGOH enhanced testosterone and progesterone productions in I-10 cells. 
2. MK-4 and GGOH regulated PKA activity in a cAMP-dependent manner in I-10 cells. 
3. MK-4 and GGOH modulated intracellular cAMP levels via enhancement of AC but 
not PDE activity in I-10 cells. 
4. MK-4 and GGOH enhanced the expressions of different steroidogenesis-related genes 
mRNA and proteins in I-10 cells. 
5. Similar roles of MK-4 and GGOH in the activation of cAMP-dependent pathway on 
steroidogenesis in I-10 cells were reported here, however, MK-4 but not GGOH regulated 
the glucose-stimulated insulin secretion via increase of intracellular cAMP levels in INS-
1 cells. 
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Fig. 1. Steroidogenesis in Leydig cells. 
 
Fig. 2. MK-4 and GGOH stimulated steroidogenesis. MK-4 (A, C) and GGOH (B, D) enhanced testosterone 
and progesterone production in I-10 cells, respectively. Cells were treated with indicated concentrations of MK-
4 or GGOH for 24 h. Testosterone and progesterone levels in the culture medium were measured by EIA. Data 
are presented as mean ± SD (n = 3). Different letters indicate significant differences (P < 0.05).  
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Fig. 3. γ-T3 stimulated steroidogenesis. γ-T3 enhanced testosterone (A) and progesterone (B) productions in I-
10 cells. Cells were treated with indicated concentrations of γ-T3 for 24 h. Testosterone and progesterone levels 
in the culture medium were measured by EIA. Data are presented as mean ± SD (n = 3). Different letters indicate 
significant differences (P < 0.05). 
 
Fig. 4. MK-4 and GGOH increased PKA activity in I-10 cells. (A) Cells were transfected with a CRE-inducible 
reporter gene and then treated with MK-4 or GGOH for 3 h. Reporter activity in cell lysate was measured with 
the luciferase assay. I-10 cells were treated with H89 and MK-4 (B) or GGOH (C) for 3 h, and progesterone 
levels in the culture medium were measured by EIA. Data are presented as mean ± SD (n = 3). Different letters 
indicate significant differences (P < 0.05).  
387
8 
 
 
 
 
Fig. 5. MK-4 and GGOH stimulated intracellular cAMP levels in I-10 cells. Cells were treated with indicated 
concentrations of MK-4 or GGOH for 1.5 h, then collected and acetylated before measuring of cAMP levels in 
cell lysates by EIA. Data are presented as mean ± SD (n = 3). Different letters indicate significant differences (P 
< 0.05). 
 
 
 
 
Fig. 6. GGOH induced progesterone production via regulation of AC in I-10 cells. Cells were treated with 
MDL12,330A and GGOH (A) or MK-4 (B) for 3 h, and progesterone levels in the culture medium were 
measured by EIA. Data are presented as mean ± SD (n = 3). Different letters indicate significant differences (P 
< 0.05). 
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Fig. 7. MK-4 and GGOH enhanced progesterone production not via PDE activity in I-10 cells. Cells were treated 
with IBMX and MK-4 (A) or GGOH (B), and progesterone levels in the culture medium were measured by EIA. 
Data are presented as mean ± SD (n = 3). (C) Effect of IBMX on cytotoxicity in I-10 cells. Cells were treated 
with indicated concentrations of MK-4 or GGOH for 24 h. Cells survivability were measured by WST-1. Data 
are presented as mean ± SD (n=6). (D, E) Progesterone levels of I-10 cells after 50 μM IBMX and MK-4 or 
GGOH treatments. Data are presented as mean ± SD (n = 3). Different letters indicate significant differences (P 
< 0.05). 
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Fig. 8. MK-4 and GGOH regulated steroidogenesis-related genes mRNA levels in I-10 cells. I-10 were treated 
with MK-4 or GGOH for 1 (left) or 3 (right) h; mRNA levels of steroidogenesis-related genes (Ac9, Cyp11a, 
and StAR) were then measured by qRT-PCR. Data are presented as mean ± SD (n = 3). Different letters indicate 
significant differences (P < 0.05). 
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Fig. 9. MK-4 and GGOH regulate steroidogenesis-related genes protein levels in I-10 cells. Cells were treated 
with GGOH for 3, 6 or 24 h, and protein levels of StAR were measured by western blotting. Data are 
presented as mean ± SD (n = 3). Different letters indicate significant differences (P < 0.05).  
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Fig. 10. MK-4 and GGOH regulate steroidogenesis-related genes protein levels in I-10 cells. Cells were treated 
with GGOH for 3, 6 or 24 h, and protein levels of Cyp11a were measured by western blotting. Data are presented 
as mean ± SD (n = 3). Different letters indicate significant differences (P < 0.05).   
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Fig. 11. Effects of Ac9 and Ac3 knockdown on progesterone production in I-10 cells. I-10 cells were transfected 
with siRNAs targeting Ac9 (A) and Ac3 (B), and progesterone levels in the culture medium were measured by 
EIA. Data are presented as mean ± SD (n = 3). *p < 0.05, **p < 0.01. 
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Fig. 12. MK-4 but not GGOH regulated glucose stimulate insulin secretion in INS-1 cells. Cells were treated 
with indicated concentrations of glucose and MK-4 or GGOH for 1 h. Insulin concentration in cultured medium 
were measured by EIA. Data are presented as mean ± SD (n=3). *p < 0.05, **p < 0.01. 
 
 
 
 
Fig. 13. MK-4 regulated glucose-stimulated insulin secretion in INS-1 cells. Cells were treated with indicated 
concentrations of glucose and MK-4 for 1 h. Insulin concentration were measured by EIA. Data are presented 
as mean ± SD (n=3). *p < 0.05, **p < 0.01. 
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Fig. 14. MK-4 but not GGOH stimulated intracellular cAMP levels in INS-1 cells. Cells were treated with 
indicated concentrations of MK-4 or GGOH for 1 h, then collected and acetylated before measuring of cAMP 
levels in cell lysates by EIA. Data are presented as mean ± SD (n = 3). Different letters indicate significant 
differences (P < 0.05). 
 
 
 
 
Fig. 15. Effects of MK-4 and GGOH on luciferase activity in INS-1 cells. Cells were transfected with a CRE-
inducible reporter gene and then treated with MK-4 (A) or GGOH (B) for 3 h. Reporter activity in cell lysates 
was measured with the luciferase assay. Data are presented as mean ± SD (n = 3).  
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Fig. 16. Effects of MK-4 and on Acs mRNA levels in INS-1 cells. Cells were treated with MK-4 or GGOH for 
30 (white) or 60 (black) min; mRNA levels of Ac6, Ac8 and Ac9 genes were then measured by qRT-PCR. Data 
are presented as mean ± SD (n = 3).
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